| 時間 | 主題 | ||||
|---|---|---|---|---|---|
13:30 ~ 13:36 |
#422 Extremity cooling for the prevention of Taxane-Induced nail changes and neuropathy in castration-resistant prostate cancer: Prospective intrapatient comparison study
講者:
Yuki Matsui
座長:
Taku NAIKI, Victor C. Lin |
Yuki Matsui |
Taku NAIKI, Victor C. Lin |
||
13:36 ~ 13:42 |
#425 Optimizing Biopsy Core Number in MRI-Fusion Prostate Biopsy: A Single-Center Experience
講者:
Po-Han Chen
座長:
Taku NAIKI, Victor C. Lin |
Po-Han Chen |
Taku NAIKI, Victor C. Lin |
||
13:48 ~ 13:54 |
#187 Association of Hyaluronic Acid Rectal Spacer Quality Metrics with Rectal Dosimetry and Acute and Late Gastrointestinal (GI) Toxicity Outcomes
講者:
Yuan-Hong Lin
座長:
Taku NAIKI, Victor C. Lin |
Yuan-Hong Lin |
Taku NAIKI, Victor C. Lin |
||
13:54 ~ 14:00 |
#201 Suprapubic vs urethral catheters post robotic-assisted radical prostatectomy Jennifer Xu
講者:
Jennifer Xu
座長:
Taku NAIKI, Victor C. Lin |
Jennifer Xu |
Taku NAIKI, Victor C. Lin |
||
14:00 ~ 14:06 |
#205 Reducing Unnecessary Biopsies in PI-RADS 3-4 Lesions Through PSA-Derived Biomarker Integration: A Decision Curve Analysis
講者:
Jen-Hao Kuo
座長:
Taku NAIKI, Victor C. Lin |
Jen-Hao Kuo |
Taku NAIKI, Victor C. Lin |
||
14:06 ~ 14:12 |
#213 Prostate Cancer Detection using Artemis Prostate Fusion biopsy in a Single Institution : A Retrospective Study
講者:
Rene Mar Utanes
座長:
Taku NAIKI, Victor C. Lin |
Rene Mar Utanes |
Taku NAIKI, Victor C. Lin |
||
14:12 ~ 14:18 |
#230 Role of systematic biopsies in suspected carcinoma prostate patients and analysis of Gleason grade group concordance between the biopsy and histopathology report following radical prostatectomy.
講者:
AVIJIT BANERJEE
座長:
Taku NAIKI, Victor C. Lin |
AVIJIT BANERJEE |
Taku NAIKI, Victor C. Lin |
||
14:18 ~ 14:24 |
#246 Focal Laser Ablation in Prostate Cancer: A systematic review and meta-analysis Ymer Bushati
講者:
Ymer Bushati
座長:
Taku NAIKI, Victor C. Lin |
Ymer Bushati |
Taku NAIKI, Victor C. Lin |
||
14:24 ~ 14:30 |
#370 Chimeric Antigen Receptor T-Cell Therapy in Metastatic Castrate-Resistant Prostate Cancer: A review of all clinical and preclinical trials.
講者:
Omattage Mahasha Perera
座長:
Taku NAIKI, Victor C. Lin |
Omattage Mahasha Perera |
Taku NAIKI, Victor C. Lin |
||
14:30 ~ 14:36 |
#196 Combined Prostate-specific Membrane Antigen Positron Emission Tomography (PSMA-PET) and multiparametric Magnetic Resonance Imaging (mpMRI) for the diagnosis of clinically significant prostate cancer (csPCa)
講者:
Kit Mun Chow
座長:
Taku NAIKI, Victor C. Lin |
Kit Mun Chow |
Taku NAIKI, Victor C. Lin |
||
14:36 ~ 14:42 |
#168 Prognostic Comparison of Surgical Modalities in Early-Stage Prostate Cancer: Development and Validation of a Survival Prediction Nomogram
講者:
Yuxuan Yang
座長:
Taku NAIKI, Victor C. Lin |
Yuxuan Yang |
Taku NAIKI, Victor C. Lin |
||
14:42 ~ 14:48 |
#283 Integrating Multi-Cohort Machine Learning and Clinical Validation to Explore Peripheral Blood mRNA Diagnostic Biomarkers for Prostate Cancer
講者:
Xingyu Zhong
座長:
Taku NAIKI, Victor C. Lin |
Xingyu Zhong |
Taku NAIKI, Victor C. Lin |
||
14:48 ~ 14:54 |
#330 Development and Validation of a Novel Technique for Precise Diagnosis of DNA Mutations in Prostate Cancer
講者:
Xingyu Zhong
座長:
Taku NAIKI, Victor C. Lin |
Xingyu Zhong |
Taku NAIKI, Victor C. Lin |
||
14:54 ~ 15:00 |
#331 Development and Application of a ctDNA Methylation Detection Platform for Prostate Cancer
講者:
Xingyu Zhong
座長:
Taku NAIKI, Victor C. Lin |
Xingyu Zhong |
Taku NAIKI, Victor C. Lin |